Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04733430

LALUCA Research Platform A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice

Sponsor: Karl Landsteiner Institute for Lung Research and Pneumological Oncology

View on ClinicalTrials.gov

Summary

This is a prospective analysis of the diagnosis and treatment of lung cancer in a real-world setting. The aim of the project is to establish a clinical platform to collect representative data on molecular testing, sequence of systemic tumor therapy and other therapies, and disease progression of patients with lung cancer. A special focus will be on molecular biomarker testing and reflex NGS testing. Another aim of the registry is the collection of quality indicators in lung cancer care. The results of the register will be used to describe the current state of care and to develop it further for the future.

Official title: Landsteiner Lung Cancer Research Platform (LALUCA) A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice

Key Details

Gender

All

Age Range

18 Years - 125 Years

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2020-04-17

Completion Date

2030-04

Last Updated

2024-03-18

Healthy Volunteers

No

Conditions

Locations (1)

Karl Landsteiner Institut für Lungenforschung und Pneumologische Onkologie

Vienna, Austria